Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our opinions or reviews. Learn how we make money.

How to buy Tilray stock | US$5.29

Own your own TLRY shares in just a few minutes.

Updated

Fact checked

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our opinions or reviews. Learn how we make money.

US$5.29
current price
US$-0.02
change
-0.377%
change %

How to buy stocks in Tilray

  1. Compare share trading platforms.To buy shares in a US company from Canada you’ll need to find a trading platform that offers access to US stock markets. If you’re just starting out, look for a platform with low brokerage and foreign exchange fees. Narrow down some brokers with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Tilray. Find the share by name or ticker symbol: TLRY. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Tilray reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At today's price of US$5.29, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Tilray, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Tilray. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Price details for Tilray (TLRY)

Open $5.36 Previous close $5.31
High $5.51 Change $-0.02
Low $5.27 Change % -0.377%
Close $5.29 Timestamp 1600200000
Volume N/A GMT offset 0

Tilray stock price

Use our graph to track the performance of TLRY stocks over time.

Compare online trading platforms

Name Product Available asset types Stock Fee Option Fee Account Fee ETF Transaction Cost
Questrade
Stocks,Bonds,Options,Mutual funds,ETFs,GICs,International Equities,IPOs,Precious Metals
$4.95 - $9.95
$9.95 + $1 per contract
$0
Free
Opt for self-directed investing and save on fees or get a pre-built portfolio and take some of the guesswork out.
loading

Compare up to 4 providers

This is not a recommendation, it represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Tilray company summary

Information last updated 2020-09-13.

Tilray (TLRY) is a leading Pharmaceuticals business based in the USA. Tilray (TLRY) is listed on the NASDAQ and employs 1646 staff.

Profile

Industry Drug Manufacturers—Specialty & Generic Currency symbol $
Code TLRY Country name USA
Type Common Stock Country ISO US
Name Tilray, Inc ISIN N/A
Exchange NASDAQ CUSIP 88688T100
Currency code USD Sector Healthcare
Currency name US Dollar Full-time employees 1646

Detailed company information

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products to patients, physicians, pharmacies, governments, and hospitals; and for researchers for commercial purposes, as well as compassionate access and clinical research applications. It operates in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, Israel, Ireland, New Zealand, South Africa, Switzerland, the United States, and the United Kingdom. The company was incorporated in 2018 and is headquartered in Nanaimo, Canada.

Disclaimer: This information provided is general in nature only and does not take into account your personal objectives, financial situation or needs. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore is not appropriate for all investors. Past performance is not an indication of future results. Seek professional advice and consider your own personal circumstances before making any decision based on this information.
Go to site